Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from telogen effluvium may not happen again after another surgery.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Telogen effluvium is a condition that causes temporary hair loss.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Weight loss can cause temporary hair loss, especially in women and older adults.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Most patients stop using topical minoxidil due to side effects.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

Skin cell-derived vesicles can help heal skin injuries effectively.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.